Caspase-2 Inhibition May Raise Age-Related Liver Cancer Risk
TL;DR Summary
Deleting Caspase-2, once considered protective against fatty liver disease, disrupts liver cell quality control, leading to polyploidy, chronic inflammation and fibrosis, and markedly increasing age-related liver cancer risk in mice.
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
7 min
vs 8 min read
Condensed
98%
1,430 → 30 words
Want the full story? Read the original article
Read on SciTechDaily